TickerFacts.

Anavex Life Sciences Corp. (AVXL): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Older than the company's other figures. The latest EBITDA is for the year ended 2014-09-30, while the company's latest annual report covers the year ended 2025-09-30. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

-$2.97M
Year ended 2014-09-30
2010-09-30: -$5.65M2011-09-30: -$6.18M2012-09-30: -$4.32M2013-09-30: -$2.14M2014-09-30: -$2.97M-$2.97M
2010-09-30 EBITDA (USD) 2014-09-30
Period endedEBITDAChange YoYSource filing
2014-09-30-$2.97Mn/m2016-12-14, From 2013-10-01
2013-09-30-$2.14Mn/m2014-12-29, From 2012-10-01
2012-09-30-$4.32Mn/m2013-12-30, From 2011-10-01
2011-09-30-$6.18Mn/m2012-12-31, From 2010-10-01
2010-09-30-$5.65Mn/a2011-12-22, From 2009-10-01